Tumescent Local Anesthesia TLA - Tumescent.com
  • Home
  • TAAD RCT
  • TLA Resources
    • TLA Tips
    • TLA Videos
    • TLA Powerpoints
      • Tumescent Drug Delivery: Lidocaine & Beyond
      • Tumescent Antibiotic Delivery (TAD)
      • Tumescent Infiltration Technique
  • Articles
    • Prevention of Surgical Site Infections and Biofilms
    • Estimated Maximal Safe Dosages of Tumescent Lidocaine
    • Tumescent Anesthesia And Modified Liposuction
    • FDA Freedom of Information (FOI) Lidocaine
    • Lidocaine Toxicity
    • Local Anesthesia Safety in Large Volume Liposuction
    • Regional Anesthesia Permits Lidocaine Doses of 35 mg/kg
    • Tumescent Technique for Liposuction – Abstract
  • Books Related TLA
    • Tumescent Technique – Liposuction Textbook
    • Local Anesthetics
    • Lectures on Treatment of Burns
    • Xylocaine
  • Blog
  • Contact

FDA Lidocaine Analysis Documents

The complete collection of documents containing the data upon which the FDA based its official 7mg/kg maximum recommended dosage for lidocaine with epinephrine for infiltration local anesthesia (obtained under the Freedom of Information Act).

1948 07 08 Astra Pharmaceuticals Xylocaine Thesis Letter To FDA

Sample Heading

1948-07-08
Astra Pharmaceuticals
Xylocaine Thesis
Letter to FDA

1948 07 08 Astra Pharmaceuticals 2nd Letter To FDA

Sample Heading

1948-07-08
Astra Pharmaceuticals
2nd Letter to FDA

1948 09 07 USMC Letter To Astra Pharmaceuticals

Sample Heading

1948-09-07
USMC Letter to
Astra Pharmaceuticals

1948 09 09 USPHS Letter To Astra Pharmaceuticals

Sample Heading

1948-09-09
USPHS letter to
Astra Pharmaceuticals

1948 09 30 John Hopkins Hospital Letter To Astra Pharmaceuticals

Sample Heading

1948-09-30
John Hopkins Hospital
letter to Astra Pharmaceuticals

1948 11 12 Dr. Lazansky From Tufts College Letter To FDA

Sample Heading

1948-11-12
Dr. Lazansky
from Tufts College
letter to FDA

1948 11 16 Dr. Bjaringer From Astra Pharmaceuticals Letter To FDA

Sample Heading

1948-11-16
Dr. Bjaringer from
Astra Pharmaceuticals
letter to FDA

1948 11 19 Nelson, FDA Letter To Astra Pharmaceuticals

Sample Heading

1948-11-19
Nelson, FDA letter
to Astra Pharmaceuticals

2010 02 01 FDA Lidocaine Epinephrine Label

Sample Heading

2010-02-01
FDA Lidocaine
Epinephrine label

2010 02 01 FOIA Letter To Dr. Klein

Sample Heading

2010-02-01
FOIA letter
to Dr. Klein

Copyright Tumescent.org - All Rights Reserved